Online citations, reference lists, and bibliographies.
← Back to Search

Serum Lipoprotein Responses During Active And Stable Weight Reduction In Reproductive Obese Females.

C. Friedman, J. Falko, S. Patel, M. Kim, H. Newman, H. Barrows
Published 1982 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
An increase in high density lipoprotein-cholesterol (HDL-C) and a reduction in low density lipoprotein-cholesterol (LDL-C) accompany weight reduction in obese males. In contrast, obese females have had variable responses in these two lipoproteins after weight reduction. To evaluate the effects of weight reduction in obese women, 15 morbidly obese eugonadotropic women of reproductive age had serum lipids and lipoproteins measured before and after achieving a stable and reduced weight by either diet and/or a gastric stapling procedure. Total testosterone (T), free testosterone (free T), and testosterone-binding globulin serum concentrations were also determined before and after achieving a stable reduced weight to assess the role of androgens in modulating any lipoprotein changes. In 10 subjects, lipid analysis was also performed during active weight loss. Total serum triglycerides fell from 106 +/- 53 to 76 +/- 30 mg/dl during active weight loss (P less than 0.025). Total cholesterol, LDL-C, HDL-C, and the LDL-C to HDL-C ratio did not change. In contrast, after achieving a stable reduced weight (mean weight reduction, 25.9 +/- 6.7 kg), HDL-C rose from 24 +/- 8 to 32 +/- 9 mg/dl (P less than 0.005). This was accompanied by a reduction in LDL-C from 145 +/- 23 to 135 +/- 30 mg/dl (P less than 0.01) and in the LDL-C to HDL-C ratio from 6.7 +/- 2.6 to 4.8 +/- 1.9 (P less than 0.001). Total triglycerides and total cholesterol were unchanged. After obtaining a stable reduced weight, testosterone-binding globulin increased and free T fell, but no significant correlation existed between the changes in androgens and the changes in lipoprotein responses. Thus, in morbidly obese women, weight reduction increases HDL-C and lowers LDL-C serum concentrations. The reduction in the LDL-C to HDL-C ratio suggests that weight loss may favorably reduce the risk of coronary artery disease in these patients. A concurrent reduction of free T with weight loss does not appear to be a major controlling influence in these lipoprotein alterations.
This paper references
10.7326/0003-4819-91-5-750
Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol.
J. Falko (1979)
10.1016/0021-9150(80)90001-5
Plasma high density lipoprotein in severe obesity after stable weight loss.
F. Contaldo (1980)
10.1210/JCEM-45-1-30
The relationship between plasma testosterone and mean LH levels in men.
R. Rosenfield (1977)
10.1016/S0140-6736(78)92465-0
INCREASED ADIPOSE-TISSUE LIPOPROTEIN-LIPASE ACTIVITY IN MODERATELY OBESE MEN AFTER WEIGHT REDUCTION
R. Schwartz (1978)
10.1001/ARCHINTE.1981.00340090038010
Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction.
K. Brownell (1981)
10.2337/diab.28.4.326
High Density Lipoproteins
J. Witztum (1979)
10.1210/JCEM-42-4-629
The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
B. Sherman (1976)
10.1093/AJCN/32.10.2016
Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss.
P. Thompson (1979)
10.1016/0002-9343(77)90874-9
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
T. Gordon (1977)
10.1093/AJCN/29.2.151
Effects of physical activity on weight reduction in obese middle-aged women.
S. Lewis (1976)
10.1210/JCEM-27-2-295
Radioimmunoassay for Human Follicle-Stimulating Hormone1
A. Midgley (1967)
10.1093/AJCN/34.10.1994
The effect of rapid weight loss due to jejunoileal bypass on total cholesterol and high-density lipoprotein.
G. M. Dobrea (1981)
10.1093/CLINCHEM/18.6.499
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
W. Friedewald (1972)
10.1007/BF02532595
Effect of androgens on serum lipids and lipoproteins
A. Solyom (2006)
10.1161/01.CIR.55.5.767
HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study
W. Castelli (1977)
10.1016/0005-2760(75)90049-1
The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein.
Y. Stein (1975)
10.1016/0021-9150(78)90178-8
Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.
E. Nikkilä (1978)
10.1146/ANNUREV.BI.46.070177.004341
The low-density lipoprotein pathway and its relation to atherosclerosis.
J. Goldstein (1977)
10.1093/CLINCHEM/22.1.98
Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique.
B. Steele (1976)



This paper is referenced by
Apoproteínas A1 y B: valores de referencia para la población de manizales
A. Vargas (1991)
10.3109/03009738509178642
Changes in lipoprotein metabolism during a supplemented fast and an ensuing vegetarian diet period.
H. Lithell (1985)
10.1177/140349489101900112
The effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health care
L. Jalkanen (1991)
10.1016/0002-8703(87)90643-0
Dietary determinants of plasma high-density lipoprotein cholesterol.
P. Pietinen (1987)
10.1016/0026-0495(85)90005-8
The effects of exercise and weight loss on plasma lipids in young obese men.
G. Sopko (1985)
10.1093/AJCN/56.2.320
Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.
A. Dattilo (1992)
Lipid profile in obesity.
M. S. Bhatti (2001)
10.2337/diacare.14.9.802
Benefits and Limitations of Very-Low-Calorie Diet Therapy in Obese NIDDM
R. Henry (1991)
10.1161/01.CIR.81.4.1293
Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.
P. Williams (1990)
10.1152/AJPENDO.1989.256.6.E740
HDL subfractions and adipose tissue metabolism in the reduced-obese state.
R. Eckel (1989)
10.1161/01.HYP.16.2.201
Optimizing cardiovascular risk reduction during antihypertensive therapy.
M. Weinberger (1990)
10.1016/0021-9150(83)90134-X
Effects on blood lipids and body weight in high risk men of a practical exercise program.
G. Sopko (1983)
10.1053/META.2002.34698
Plasma kinetics of a chylomicron-like emulsion in normolipidemic obese women after a short-period weight loss by energy-restricted diet.
M. R. Oliveira (2002)
10.1007/978-1-4684-1262-8_6
HDL binding to human adipocyte plasma membranes: regional variation in omental and subcutaneous depots.
B. Fong (1986)
10.1016/0002-9343(87)90892-8
Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
J. Falko (1987)
10.1007/BF01721038
Chronic hyperprolactinemia and plasma lipids in women
H. Heshmati (2005)
10.1111/j.1365-2362.1987.tb01220.x
Regional variation in high‐density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects
A. Salter (1987)
Anthropometric measurements and lipid Profile Study during Ramadan Fasting
M. Y. Altaee (2005)
10.1161/01.ATV.4.2.115
Effect of Weight Loss in Moderate Obesity on Plasma Lipoprotein and Apolipoprotein Levels and on High Density Lipoprotein Composition
J. Zimmerman (1984)
10.1016/0021-9150(92)90242-9
Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women.
R. Leenen (1992)
Anthropometric measurements and lipid Profile Study during
M. Younis (2005)
10.1007/978-94-011-6716-1_3
Medical Indications for Weight Reduction
C. Lucas (1984)
10.1016/0026-0495(87)90012-6
The independent effects of dietary weight loss and aerobic training on high density lipoproteins and apolipoprotein A-I concentrations in obese men.
R. Schwartz (1987)
Morbidity and treatment of clinically important obesity: an internal medicine perspective.
J. D. Fachnie (1988)
10.1001/ARCHPEDI.1992.02160150043017
Beneficial effects of dietary intervention on serum lipid and apolipoprotein levels in obese children.
H. Endo (1992)
10.2337/diacare.20.11.1744
The Prevention and Treatment of Obesity: Application to type 2 diabetes
C. Maggio (1997)
Semantic Scholar Logo Some data provided by SemanticScholar